Behçet’s disease is a rare chronic inflammatory disorder that affects multiple body systems.

The disease causes inflammation in blood vessels throughout the body and can lead to symptoms involving the mouth, skin, eyes, joints, nervous system, and gastrointestinal tract.

Because researchers still do not fully understand the exact cause and progression of the

disease, high-quality Behçet’s disease patient samples play a critical role in advancing medical research.

At Bay Biosciences, we support autoimmune disease research by providing high-quality autoimmune disease biospecimens, including human serum and plasma samples, PBMC samples for research, whole blood specimens, and other clinical research samples.

These biospecimens support biomarker discovery, translational research, immunology studies, and precision medicine initiatives.

Behçet’s Disease Patient Samples for Research

Understanding Behçet’s Disease

Behçet’s disease belongs to a group of autoimmune and autoinflammatory disorders in which the immune system mistakenly attacks healthy tissues and blood vessels.

The disease often develops in early adulthood and may progress through periods of flare-ups and remission.

Researchers believe that immune dysregulation, abnormal inflammatory responses, and genetic susceptibility all contribute to disease development.

Symptoms of Behçet’s Disease

Behçet’s disease symptoms vary depending on the organs affected and the severity of inflammation.

Common symptoms include:

Risk Factors of Behçet’s Disease

Common risk factors include:

Researchers continue to investigate how these factors interact to trigger abnormal immune activation and vascular inflammation.

Pathophysiology of Behçet’s Disease

In Behçet’s disease, immune system dysfunction triggers excessive inflammation throughout the body.

Immune cells attack blood vessels and healthy tissues, leading to chronic inflammatory damage.

Several immune cells contribute to this process, including:

  • T lymphocytes
  • Neutrophils
  • Monocytes
  • Natural killer cells

These cells release inflammatory cytokines and signaling molecules that intensify tissue inflammation and vascular injury.

Moreover, researchers have observed increased neutrophil activation, oxidative stress, and inflammatory mediator production in many Behçet’s disease patients.

These inflammatory responses have been found to contribute to ulcer formation, vascular complications, and tissue inflammation.

Diagnosis and Clinical Evaluation

Doctors diagnose Behçet’s disease using a combination of clinical evaluation, patient history, physical examination, and laboratory testing.

Since no single laboratory test confirms the disease, clinicians carefully evaluate symptom patterns and inflammatory findings.

During diagnosis, healthcare providers assess:

  • Frequency of oral and genital ulcers
  • Skin abnormalities
  • Eye inflammation
  • Neurological symptoms
  • Vascular involvement
  • Gastrointestinal manifestations

Doctors may also perform:

  • Blood tests to rule out any other possible diseases
  • Eye examinations
  • Imaging studies
  • Neurological assessments
  • Pathergy testing

Pathergy testing evaluates abnormal skin hypersensitivity by observing how the skin reacts to minor injury.

Researchers also analyze clinical research samples to identify biomarkers that may improve diagnostic accuracy and disease classification.

Treatment and Disease Management

Healthcare providers use multiple treatment approaches to reduce inflammation, control symptoms, and prevent complications.

Treatment strategies vary depending on disease severity and organ involvement.

Common treatment options include:

  • Corticosteroids to reduce inflammation
  • Immunosuppressive medications
  • Biologic therapies targeting inflammatory pathways
  • Colchicine for joint and mucosal symptoms
  • Pain management therapies
  • Topical treatments for ulcers

Importance of Behçet’s Disease Patient Samples

Behçet’s disease patient samples provide researchers with direct biological material from affected individuals.

Researchers use these samples to:

  • Identify biomarkers associated with disease activity
  • Study inflammatory signaling pathways
  • Investigate immune cell dysfunction
  • Evaluate treatment responses
  • Support biomarker discovery programs
  • Develop targeted therapies
  • Improve diagnostic accuracy

Moreover, clinical researchers also compare samples from patients with Behçet’s disease with those from healthy controls to better understand disease-specific immune abnormalities.

Types of Biospecimens Used in Behçet’s Disease Research

1. Human Serum and Plasma Samples

Human serum and plasma samples remain among the most commonly used biospecimens in Behçet’s disease research.

Researchers analyze serum and plasma to measure:

  • Cytokines
  • Chemokines
  • Autoantibodies
  • Inflammatory proteins
  • Growth factors
  • Immune mediators

2. PBMC Samples for Research

PBMC samples for research play an especially important role in autoimmune and inflammatory disease studies.

Peripheral Blood Mononuclear Cells (PBMCs) include:

  • Lymphocytes
  • T cells
  • B cells
  • Natural killer cells
  • Monocytes

Researchers isolate PBMCs from whole blood samples to study immune cell behavior and inflammatory responses in Behçet’s disease patients.

3. Whole Blood Samples

Whole blood samples provide valuable information for genetic, molecular, and hematological studies.

Researchers use whole blood to:

  • Perform DNA extraction
  • Conduct genetic testing
  • Analyze inflammatory markers
  • Study immune cell counts
  • Investigate gene expression

Genetic studies involving Behçet’s disease patient samples have identified associations between the disease and certain genetic markers, including HLA-B51.

Moreover, whole blood specimens also support longitudinal monitoring studies that track disease progression and treatment response over time.

4. Tissue Biospecimens

In some studies, researchers collect tissue samples from affected organs or lesions to better understand local inflammatory mechanisms.

These tissue biospecimens may include:

  • Skin biopsies
  • Mucosal tissue samples
  • Gastrointestinal tissue biopsies

Tissue-based research helps scientists examine immune cell infiltration, vascular inflammation, and tissue-specific immune responses directly within affected areas.

Role of Clinical Research Samples in Drug Development

Clinical research samples remain essential for developing new therapies for Behçet’s disease.

Pharmaceutical companies and research organizations use these samples during:

  • Biomarker discovery studies
  • Drug efficacy testing
  • Immunology research
  • Clinical trial development
  • Companion diagnostic development

Future Directions in Behçet’s Disease Research

Emerging technologies continue to transform Behçet’s disease research. Advanced applications now include:

  • Single-cell sequencing
  • Spatial transcriptomics
  • Proteomics
  • Cytokine profiling
  • Machine learning analysis
  • Multi-omics integration

These advancements will eventually lead to:

  • Earlier diagnosis
  • Improved disease monitoring
  • Personalized treatment plans
  • More targeted therapies
  • Better long-term patient outcomes

Supporting Your Research With Bay Biosciences

We provide a wide range of high-quality, ethically sourced autoimmune disease biospecimens to support your scientific and clinical research. These include:

Our biospecimens support biomarker discovery, immunology research, therapeutic development, and precision medicine initiatives.

If you have any questions, concerns, or special requests, please don’t hesitate to contact us.